MedPath

Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome

Not Applicable
Active, not recruiting
Conditions
Down Syndrome
Registration Number
NCT04668001
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The aim of this study is to better understand the effects of transcranial photobiomodulation (tPBM) on neural oscillations of individuals diagnosed with Down syndrome.

Detailed Description

This study will compare the effect of tPBM to sham tPBM on gamma neural oscillations in the brain as assessed by EEG, and on language, attention and memory as assessed by neuropsychological testing. Participants will be randomized to either tPBM with near-infrared light (tPBM-NIR) or tPBM-Sham and will undergo 18 treatments (3 treatments per week for 6 weeks) in addition to baseline, short-term and long- term follow up visits.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
19
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Cambridge Neuropsychological Test Automated BatteryBaseline to Post-Treatment (~6 weeks)

Reaction Time, Paired Associative Learning, and Motor Screening Task subtests

Change in EEGBaseline to Post-Treatment (~6 weeks)

Gamma Power (40 Hz) of EEG Signal

Change in Wordless Picture BookBaseline to Post-Treatment (~6 weeks)

Standardized narrative sampling tasks that measure intelligibility, vocabulary, syntax and grammar of language

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Massachusetts General Hospital at the Charlestown Navy Yard

🇺🇸

Charlestown, Massachusetts, United States

Massachusetts General Hospital at the Charlestown Navy Yard
🇺🇸Charlestown, Massachusetts, United States
© Copyright 2025. All Rights Reserved by MedPath